IL17A and colitis: Pretreatment of colitis mice with L. reuteri I5007 significantly reduced the DSS-induced production of TNF-α, IL-6, IFN-γ, and IL-17A, as well as increased the level of IL-10 compared with the DSS group (Figure 3B).